07 October 2026
- Financial press releases
- €8.2 million in gross cash collections from paid early access programs since the start of treatments in March 2026, including €1.7 million during the third quarter
- Paid early access programs continue to generate cash and support the Company's operating activities.
- €0.7 million in cash and cash equivalents as of September 30, 2026